Position in HLN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$99,765
-$27,952 QoQ
Shares Held
10,693
-16.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#387
of 639 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Moors & Cabot, Inc. holds $1,565,307 across 4 Drug Manufacturers - Specialty & Generic names. HLN ranks #4 (6.4% of the industry book) .
All Filings in HLN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $99,765 | 10,693 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $127,717 | 12,759 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $165,136 | 16,334 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $146,515 | 16,334 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $187,033 | 18,036 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $185,590 | 18,036 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $189,989 | 19,915 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $213,187 | 20,150 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $160,244 | 19,400 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $169,800 | 20,000 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $169,538 | 20,600 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $174,930 | 21,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $184,276 | 21,990 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $177,370 | 21,790 | Shares | Sole | 2023-05-05 | |
| 2022-09-30 | $149,923 | 24,618 | Shares | Sole | 2022-11-08 | |
| No filing history on record for this holder in this stock. | ||||||